Skip to main content

Main menu

  • Home
  • About
    • Clinical Chemistry
    • Editorial Board
    • Most Read
    • Most Cited
    • Alerts
    • CE Credits
  • Articles
    • Current Issue
    • Early Release
    • Future Table of Contents
    • Archive
    • Browse by Subject
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
    • Permissions & Reprints
  • Resources
    • AACC Learning Lab
    • Clinical Chemistry Trainee Council
    • Clinical Case Studies
    • Clinical Chemistry Guide to Scientific Writing
    • Clinical Chemistry Guide to Manuscript Review
    • Journal Club
    • Podcasts
    • Q&A
    • Translated Content
  • Abstracts
  • Submit
  • Contact
  • Other Publications
    • The Journal of Applied Laboratory Medicine

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
Clinical Chemistry
  • Other Publications
    • The Journal of Applied Laboratory Medicine
  • Subscribe
  • My alerts
  • Log in
Clinical Chemistry

Advanced Search

  • Home
  • About
    • Clinical Chemistry
    • Editorial Board
    • Most Read
    • Most Cited
    • Alerts
    • CE Credits
  • Articles
    • Current Issue
    • Early Release
    • Future Table of Contents
    • Archive
    • Browse by Subject
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
    • Permissions & Reprints
  • Resources
    • AACC Learning Lab
    • Clinical Chemistry Trainee Council
    • Clinical Case Studies
    • Clinical Chemistry Guide to Scientific Writing
    • Clinical Chemistry Guide to Manuscript Review
    • Journal Club
    • Podcasts
    • Q&A
    • Translated Content
  • Abstracts
  • Submit
  • Contact
NewsClinical Chemist

Antimicrobial Resistance—Could Less Really Be More?

Eleanor A. Powell, Esther Babady
DOI: 10.1373/clinchem.2016.263954 Published October 2016
Eleanor A. Powell
Department of Laboratory Medicine, Clinical Microbiology Service, Memorial Sloan Kettering Cancer Center.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esther Babady
Department of Laboratory Medicine, Clinical Microbiology Service, Memorial Sloan Kettering Cancer Center.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: babadyn@mskcc.org
  • Article
  • Info & Metrics
  • PDF
Loading

In the United States, antibiotic resistance was responsible for over 2000 000 infections and more than 20000 deaths in 2013. In an effort to address this growing threat, the White House issued the National Action Plan for Combating Antibiotic-Resistant Bacteria in March 2015. The plan includes several goals, the first of which is to slow the emergence and spread of antimicrobial resistance. Similarly, in May 2015, the WHO released its Global Action Plan on Antimicrobial Resistance, calling for optimization of the use of antimicrobial agents.

Innovative approaches to successfully stem the tide of antimicrobial resistance are urgently needed. A recent feature in Science profiled one such potential approach to antimicrobial use where antibiotics are administered at lower doses, just enough to reduce the concentration of susceptible bacteria and allow the immune system to fully clear the infection (1). This approach, put forth by evolutionary biologists, is at odds with the current dogma established by Dr. Paul Ehrlich at the beginning of the 19th century, which advocates treatment of patients as aggressively as possible (i.e., highest possible dose) to kill bacteria.

So, could less be more? The proposed strategy of lower dosage is based on the idea that most infections are heterogeneous, with both susceptible and resistant organisms present, and using high doses of antibiotics destroys the susceptible population, allowing resistant organisms to flourish. Instead, an approach that maintains enough susceptible organisms to compete with resistant ones may prevent the emergence and spread of antibiotic resistance. This approach has similarities to other novel treatment concepts including fecal transplant to restore the gut microbiome and prevent Clostridium difficile overgrowth and the use of shorter courses of antimicrobials therapy to treat common infections.

Reduced dosing of antimicrobial agents may have several potential limitations. In vitro studies have shown that suboptimal levels of bactericidal antibiotics can promote antibiotic resistance through DNA damage by reactive oxygen species. Antimicrobial resistance frequently arises in patients on long-term antimicrobial therapy for prophylaxis or difficult-to-control infections. In these patients, the immune system is often highly suppressed and giving lower antimicrobial doses may be an ineffective strategy. The emergence of resistance varies among drugs (e.g., bacteriostatic vs bactericidal) and among the various drug-pathogen combinations. Finally, innate differences in host metabolism, such as differences in rates of absorption and/or clearance of drugs, may prevent a universal implementation of this strategy.

Stronger collaborative research between clinicians, scientists and pharmaceutical companies will be necessary to evaluate the effectiveness of prescribing lower doses of antibiotic and its impact on preventing antibiotic resistance. However, this approach is in line with the national and global plans to combat antibiotic resistance in that it supports the judicious use of antibiotics and provides novel ideas to achieve it.

Footnotes

  • Author Contributions: All authors confirmed they have contributed to the intellectual content of this paper and have met the following 3 requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; and (c) final approval of the published article.

  • Authors' Disclosures or Potential Conflicts of Interest: No authors declared any potential conflicts of interest.

  • Received for publication August 16, 2016.
  • Accepted for publication August 22, 2016.
  • © 2016 American Association for Clinical Chemistry

Reference

  1. 1.↵
    1. Kupferschmidt K
    . Resistance fighters. Science 2016;352:758–61.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top

In this issue

Clinical Chemistry: 62 (11)
Vol. 62, Issue 11
November 2016
  • Table of Contents
  • About the Cover
  • Index by author
  • Table of Contents (PDF)
  • Cover (PDF)
  • Advertising (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
  • Audio summary of this issue
Print
Share
Antimicrobial Resistance—Could Less Really Be More?
Eleanor A. Powell, Esther Babady
Clinical Chemistry Nov 2016, 62 (11) 1544; DOI: 10.1373/clinchem.2016.263954
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Antimicrobial Resistance—Could Less Really Be More?
Eleanor A. Powell, Esther Babady
Clinical Chemistry Nov 2016, 62 (11) 1544; DOI: 10.1373/clinchem.2016.263954

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • Reference
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Clinical Chemist

  • NEJM Knowledge+/AACC Learning Lab Contributors 2019
  • A 54-Year-Old Man with Complicated Blood Bank Antibody Testing
  • Clinical Chemistry's Invited Reviewers 2019
Show more Clinical Chemist

News & Views

  • NEJM Knowledge+/AACC Learning Lab Contributors 2019
  • Clinical Chemistry's Invited Reviewers 2019
  • “Reaching Out to the World” Appreciation
Show more News & Views

Similar Articles

Subjects

  • SUBJECT AREAS
    • Infectious Disease

Options

  • Home
  • About
  • Articles
  • Information for Authors
  • Resources
  • Abstracts
  • Submit
  • Contact
  • RSS

Other Publications

  • The Journal of Applied Laboratory Medicine
Footer logo

© 2019 American Association for Clinical Chemistry

Powered by HighWire